These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 11675351)
1. Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Qin JZ; Zhang CL; Kamarashev J; Dummer R; Burg G; Döbbeling U Blood; 2001 Nov; 98(9):2778-83. PubMed ID: 11675351 [TBL] [Abstract][Full Text] [Related]
2. Constitutive and interleukin-7/interleukin-15 stimulated DNA binding of Myc, Jun, and novel Myc-like proteins in cutaneous T-cell lymphoma cells. Qin JZ; Dummer R; Burg G; Döbbeling U Blood; 1999 Jan; 93(1):260-7. PubMed ID: 9864169 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma. Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151 [TBL] [Abstract][Full Text] [Related]
4. Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells. Qin JZ; Kamarashev J; Zhang CL; Dummer R; Burg G; Döbbeling U J Invest Dermatol; 2001 Sep; 117(3):583-9. PubMed ID: 11564163 [TBL] [Abstract][Full Text] [Related]
5. Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma. Kamijo H; Miyagaki T; Shishido-Takahashi N; Nakajima R; Oka T; Suga H; Sugaya M; Sato S Blood; 2018 Nov; 132(18):1922-1935. PubMed ID: 30194255 [TBL] [Abstract][Full Text] [Related]
7. Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression. Netchiporouk E; Litvinov IV; Moreau L; Gilbert M; Sasseville D; Duvic M Cell Cycle; 2014; 13(21):3331-5. PubMed ID: 25485578 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain. van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637 [TBL] [Abstract][Full Text] [Related]
10. Spontaneous interleukin-5 production in cutaneous T-cell lymphoma lines is mediated by constitutively activated Stat3. Nielsen M; Nissen MH; Gerwien J; Zocca MB; Rasmussen HM; Nakajima K; Röpke C; Geisler C; Kaltoft K; Ødum N Blood; 2002 Feb; 99(3):973-7. PubMed ID: 11807001 [TBL] [Abstract][Full Text] [Related]
11. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169 [TBL] [Abstract][Full Text] [Related]
12. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246 [TBL] [Abstract][Full Text] [Related]
13. Characterization of cytokine differential induction of STAT complexes in primary human T and NK cells. Yu CR; Young HA; Ortaldo JR J Leukoc Biol; 1998 Aug; 64(2):245-58. PubMed ID: 9715265 [TBL] [Abstract][Full Text] [Related]
14. Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells. Chang TP; Poltoratsky V; Vancurova I J Immunol; 2015 Mar; 194(6):2942-53. PubMed ID: 25681335 [TBL] [Abstract][Full Text] [Related]
15. Experimental regulation of STAT gene expression reveals an involvement of STAT5 in interleukin-4-driven cell proliferation. Friedrich K; Wietek S Biol Chem; 2001 Feb; 382(2):343-51. PubMed ID: 11308032 [TBL] [Abstract][Full Text] [Related]
16. SHP2 regulates IL-2 induced MAPK activation, but not Stat3 or Stat5 tyrosine phosphorylation, in cutaneous T cell lymphoma cells. Lundin Brockdorff J; Woetmann A; Mustelin T; Kaltoft K; Zhang Q; Wasik MA; Röpke C; Ødum N Cytokine; 2002 Nov; 20(4):141-7. PubMed ID: 12543077 [TBL] [Abstract][Full Text] [Related]
17. Stromal cells provide signals different from cytokines for STAT5 activation in hematopoietic cells. Sato AK; Yanai N; Okubo T; Mori KJ; Obinata M Cell Struct Funct; 2001 Apr; 26(2):95-101. PubMed ID: 11482458 [TBL] [Abstract][Full Text] [Related]
18. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma. Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239 [TBL] [Abstract][Full Text] [Related]
19. Distinct palindromic extensions of the 5'-TTC...GAA-3' motif allow STAT6 binding in vivo. Kraus J; Börner C; Höllt V FASEB J; 2003 Feb; 17(2):304-6. PubMed ID: 12475891 [TBL] [Abstract][Full Text] [Related]
20. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line. Dumon S; Santos SC; Debierre-Grockiego F; Gouilleux-Gruart V; Cocault L; Boucheron C; Mollat P; Gisselbrecht S; Gouilleux F Oncogene; 1999 Jul; 18(29):4191-9. PubMed ID: 10435632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]